nimodipine has been researched along with Meningitis, Pneumococcal in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we investigated the effect of the calcium channel blocker nimodipine on the pathophysiologic alterations during experimental pneumococcal meningitis in rats." | 7.70 | Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis. ( Koedel, U; Paul, R; Pfister, HW, 2000) |
| "In this study, we investigated the effect of the calcium channel blocker nimodipine on the pathophysiologic alterations during experimental pneumococcal meningitis in rats." | 3.70 | Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis. ( Koedel, U; Paul, R; Pfister, HW, 2000) |
| "It was investigated whether treatment with the calcium channels blocker Nimodipine, a 1,4-dihydropyridine derivative, influences vasculopathy and neuronal injury in experimental pneumococcal meningitis." | 3.69 | Effects of nimodipine on the cerebrovascular and neuronal changes during pneumococcal meningitis in the rat. ( Ayaz, C; Ceviz, A; Geyik, MF; Hoşoglu, S; Inalöz, S; Kemaloglu, MS; Kökoglu, OF; Sari, I, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoşoglu, S | 1 |
| Ceviz, A | 1 |
| Kemaloglu, MS | 1 |
| Sari, I | 1 |
| Inalöz, S | 1 |
| Geyik, MF | 1 |
| Kökoglu, OF | 1 |
| Ayaz, C | 1 |
| Paul, R | 1 |
| Koedel, U | 1 |
| Pfister, HW | 1 |
2 other studies available for nimodipine and Meningitis, Pneumococcal
| Article | Year |
|---|---|
Effects of nimodipine on the cerebrovascular and neuronal changes during pneumococcal meningitis in the rat.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Humans; Meningitis, Pneumococcal; Neurons | 1997 |
Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Interleukin-6; Intracranial Pressure; Luminescent | 2000 |